









High doses of garlic extract significantly
attenuated the ratio of serum LDL to HDL
level in rat-fed with hypercholesterolemia diet
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Abstract
Background: Hypercholesterolemia is associated with an increased risk of heart disease. In this study, we
investigated the antihyperlipidemic effects of garlic (Allium sativum L.) in rat models of hypercholesterolemic.
Methods: Wistar male rats were randomly divided into 4 diet groups with garlic supplementation. Male Wistar rats
were fed by standard pellet diet (group I), standard diet supplemented with 4 % garlic (group II), lipogenic diet
(containing sunflower oil, cholesterol and ethanol) equivalent to 200 mg raw garlic/kg body weight (raw) (group III)
and lipogenic diet equivalent to 400 mg raw garlic/kg body weight (raw) (group IV).
Results: Rats fed 400 g/kg garlic extract(GE), had a significantly lower concentration of serum low-density lipoprotein
cholesterol (LDL-C) cholesterol and elevated HDL –C cholesterol at day 28 (P < 0.05).In addition,serum levels of LDL-C
was lower in the III and IV group than those in the IV group (P < 0.001 for each). However, cholesterol efflux capacity
was positively correlated with HDL cholesterol concentration (P < 0 · 0001). It was also directly correlated with garlic
supplementation (P < 0 · 0001).
Conclusion: Together Taken, the results are clearly indicative of the beneficial effects of garlic in reducing lateral side
effects of hyperlipidemia. Our data demonstrate that GE has protective effects on HDL in rats with high LDL intake.
Therefore, it could be used to remedy hypercholesterolemia with help reduce risk of coronary heart disease
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
1834155749171141
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Background
Hyperlipidemia is a major risk factor involved in ischemic
heart disease. The prevalence of hyperlipidemia as well as
its complications is increasing in the world. Moreover, al-
terations in serum lipid and lipoprotein levels result in a
variety of chronic diseases such as coronary heart diseases
(CHD) and atherosclerosis [1]. CHD is a major health
problem in developed countries, and atherosclerosis is the
principal contributor to the pathogenesis of myocardial
and cerebral infarction [2], which in this case, there is con-
vincing evidence that relaxation mediated by endothelium-
derived nitric oxide (NO) is impaired in arteries from hy-
percholesterolemic and atherosclerotic animals [3, 4].
Many studies have now shown that elevated concentra-
tions of total or LDL cholesterol in the blood are powerful
risk factors for CHD [5], whereas high concentrations of
HDL cholesterol or a low LDL (or total) to HDL choles-
terol ratio may protect against CHD [2, 6].
Recent studies have directed their efforts toward the
protective effects of plants such as garlic on hyperlipid-
emia [7, 8]. During the last few decades, the hypolipidemic
effect of garlic and onion has been confirmed by many in-
vestigators, and many medications in the market that
control hypercholesterolemia and hypertriglyceridemia.
There have also been reports on the beneficial effects
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of garlic extract and oil in controlling hyperlipidemia in
animals [7–13].
Garlic (Allium sativum L.) has long been used widely
not only as a flavoring agent but also as a folk medica-
tion and is one of the most well-known herbal medicines
worldwide and there has been increasing interest in
using garlic as a cholesterol-lowering agent. Its reported
beneficial actions and its compounds have been reported
to have diverse biological activities such as cholesterol
and triglyceride-lowering effects [14, 15],antimicrobial
[16], antithrombotic [17], antihypertensive [18, 19] and
anti-hyperlipidemic effects [20, 21],regulating plasma
lipid levels, anti-carcinogenic, lead and mercury detoxifi-
cation, antioxidant,, anti-diabetic, and various other bio-
logical actions [22–25]. Also, garlic has cardio-protective
effects as it may help decrease TC, LDL- C and blood
pressure while raising high HDL [26, 27]. The aim of
this study was to evaluate of the anti-hyperlipidemic,
and anti-hypercholesterolemic activities of garlic extract
(GE) at doses of 200 and 400 mg/kg body weight for 2
and 4weeks, intraperitoneal (i.p.) prior to the induction
of HDL/LDL, was investigated against hyperlipidemic/
hypercholesterolemic in male rats
Methods
Animals and animal ethics/and or welfare
Forty healthy male Wistar albino rats weighing 200–250
grams were obtained from the Animal Care Center at Col-
lege of Medicine, Shiraz University. Animals were housed
in wire cages(four per cage,and rats were kept in individ-
ual propylene cages under standard laboratory conditions
by the dimensions of 30 × 50 × 25 cm3 two by two,1 month
before the start of the experiments, and maintained under
a daily controlled lighting cycle(12 h-light and 12 h-dark)
at 22 + 2 °C and 60 % humidity with free access to rat diet
and tap water for one week to adapt to the laboratory en-
vironment prior to the experiments. Animals were kept
for 4 weeks to allow acclimatization to the animal facility
before starting the experiments.
All animals received human care according to the criteria
outlined in the “Guide for the Care and Use of Laboratory
Animals” prepared by the National Academy of Sciences
and published by the National Institutes of Health
Preparation of garlic extracts
Garlic bulbs utilized in these studies was purchased from
a local grocery herb store in Shiraz, Iran. The garlic
powder was prepared from fresh garlic bulb, which was
heat-dried at 60–70 °C, and then ground by a mill.
Volatile compounds in the garlic powder were analyzed
by gas chromatography using daily disulfide as a stand-
ard [28, 29]. All garlic derivatives were stored at 4 °C
and stocks of the water-soluble compounds were made
fresh every time before use. Briefly, garlic cloves were
peeled and homogenized with a small amount of quartz
sand in 20 mmol/LTris–HCl buffer (pH 7.4), and the deb-
ris was removed by centrifugation at 21,000 × g for 20 min
at 25 °C. Subsequently, 30 g and 60 g of the powdered
seeds were added to 400 ml and 800 ml of distilled water,
and the extraction was obtained by steam distillation. The
distillation process was continued until 200 mg/kg and
400 mg/kg of distillate were collected. The distillate was
extracted three times with hydro-alcoholic liquid
Experimental protocol/or procedure and treatments
The rats were divided into four groups and randomly al-
lotted into one of four experimental groups each group
contained ten animals. The control group was fed a stand-
ard diet (normal control)(for first stage 15 days and sec-
ond stage 30 days) (n = 10), and test animals in group II
was fed a standard diet plus 10 % cholesterol-enriched
high-fat (U.A.R., Paris, France; hypercholesterolemic con-
trols) (for 2 weeks and 4 weeks) (n = 10);
Groups III and IV, the rats were fed with a lipogenic diet
containing standard pellet diet supplemented with 0.5 %
(w/w) cholic acid, 20 % (w/w) sunflower oil and 2 % (w/w)
cholesterol for at least two weeks to produce hyperlipid-
emia. Additionally, groups III and IV drank water contain-
ing 3 % (v/v) ethanol). Groups III and IV received garlic
extract as an intraperitoneal (IP) dose of 200 and 400 mg/
kg/bw (for 2 and 4 weeks) (garlic diet, n = 10), respectively.
In addition, the garlic extract in experimental group was
injected intraperitoneally. Blood samples were collected
into test tubes containing EDTA through cardiac puncture.
The plasma samples were separated by low speed centrifu-
gation (2000 g) for 10 min and were stored at _80 _C until
they were analyzed. All animal procedures were performed
with regard to Iranian animal ethics society and local uni-
versity rules.
Plasma biochemical measurements/and or biochemical
assay of serum lipids
Blood samples were taken directly from the heart in a cen-
trifuge tube and allowed to form serum and processed as
previously described, however, in each rat was determined
after the start the treatment and every 15 d in total 2
times, and or can be expressed that after the 4-weeks
treatment, the rats were killed using urethane anesthesia.
The blood was collected by cardiac puncture and allowed
to clot, and the clotted blood was then centrifuged at
4500 × g for 10 min. The serum was separated and stored
at −80 °C for HDL and LDL analysis, and these serum
concentrations were determined with commercially avail-
able enzyme kits (BioMerieux, Marcy, France).
Statistical analysis
All data are presented as means ± SEM. Statistical ana-
lyses were analyzed using one-way ANOVA and two-









way ANOVA, and significant differences between means
were evaluated by the Tukey’s range post-hoc test com-
pare between experimental groups. Differences with P <
0.05 were considered significant.
Results
The effect of processed garlic on density lipoprotein-
cholesterol characteristics is shown in Tables 1, 2, 3, 4, 5
and 6. After 2 and 4 weeks of treatment, LDL-c and
HDL-c,decreased and increased significantly in the dif-
ferent groups, compared with control(I) and rats fed a
diet enriched with high cholesterol groups(II),respec-
tively, (P < 0.05).
Plasma lipid profiles of LDL-c level
First stage; between 1–15 days (2 weeks): Tables 1 and 2
shows that between groups 2 and 4 induced a significant
increase in serum LDL-C (P <0/05) and a significant de-
crease in the serum LDL-C level in comparison with the
control. Also, between 3 and 4, there is a significant
difference (P <0/05) and showed a significant decrease
in serum LDL-C level, when compared to that of groups
I and II (Fig. 1)(Tables 1 and 2).
Second stage; between 1–30 days (4 weeks): Tables 1
and 3 reveals a significant decrease of serum LDL-C
level between groups 1 and 4 (P <0/05). Furthermore,
this significant decrease in between groups 1 and 2, 1
and 3, 1 and 4 were observed in groups fed the proc-
essed garlic-supplemented diet (P <0.05), so the plasma
LDL in treated groups decreased significantly, compared
with those of I and II groups. Finally, LDL-cholesterol
did show significant change and, demonstrating that
dietary supplementation with processed garlic improved
lipid profiles (Fig. 2)(Tables 1 and 3).
Plasma lipid profiles of HDL-c level
First stage; between 1–15 days (2 weeks): Table 4 and 5
indicates that between groups 1 and 2, 2 and 4, 5 and 6
created a significant increase in serum HDL-C (P <0/05)
and a significant increase in the serum HDL-C level in
Table 1 Effects of daily administration of garlic extract on plasma LDL profile for 2 and 4 weeks in male albino Wistar rats. The 95 %
confidence interval of recalculated
Time Groups Mean ± SEM Lower bound Upper bound
2wk Control 18.4000 ± 2.07364 15.8252 20.9748
2wk hypercholesterolemic controls 25.8000 ± 1.48324 23.9583 27.6417
2wk dose of 200 mg/kg/bw of garlic extract 21.8000 ± 8.22800 11.5836 32.0164
2wk dose of 400 mg/kg/bw of garlic extract 19.2000 ± 3.49285 14.8631 23.5369
2wk Total 85.2000 ± 2.87364 18.5075 22.3591
4wk Control 11.4000 ± 4.33590 6.0163 16.7837
4wk hypercholesterolemic controls 24.2000 ± 8.28855 13.9084 34.4916
4wk dose of 200 mg/kg/bw of garlic extract 22.8000 ± 2.86356 19.2444 26.3556
4wk dose of 400 mg/kg/bw of garlic extract 16.2000 ± 3.83406 11.4394 20.9606
4wk Total 41.1000 ± 9.92418 15.3125 20.0342
Table 2 Effects of daily administration of garlic extract on plasma LDL profile for 2 weeks in male albino Wistar rats
Groups Compared with groups Mean difference (I-J) Std. Error Sig. Lower bound Upper bound
1 2 -.80000 2.49933 .999 −8.5278 6.9278
3 4.00000 2.49933 .606 −3.7278 11.7278
4 −7.40000 2.49933 .066 −15.1278 .3278
2 1 6.60000 2.49933 .126 −1.1278 14.3278
3 11.40000 2.49933 .002 3.6722 19.1278
4 7.40000 2.49933 .066 -.3278 15.1278
3 1 2.60000 2.49933 .899 −5.1278 10.3278
2 3.40000 2.49933 .749 −4.3278 11.1278
4 −4.00000 2.49933 .606 −11.7278 3.7278
4 1 −6.60000 2.49933 .126 −14.3278 1.1278
2 .80000 2.49933 .999 −6.9278 8.5278
3 4.80000a 2.49933 .415 −2.9278 12.5278
aSignificant as compared to another groups









comparison with I and II groups,the other expression,
serum levels of HDL-cholesterol were also increased in
the garlic supplemented group compared to those in the
control group, there was statistically significant difference
in lipid profile among various groups at the beginning of
the study. A significant (p <0.05) increase in the level of
HDL was observed on IP administration of HDL-c. By
comparing the different animal groups, it was observed
that rats which received garlic extracts showed the utmost
reduction in serum HDL-C levels compared to those
which received garlic alone (Fig. 3) (Tables 4 and 5).
Second stage; between 1–30 days (4 weeks): Table 4
and 6 demonstrates that between groups 2 and 3, 2 and
4, as well as groups 1 and 3, 2 and 3 a significant in-
crease in serum HDL-C in comparison with I and II
groups (P <0/05). In total, in treated group, a significant
increase (p < 0.05) in serum HDL levels was detected
compared to I and II groups. To warp up, the test group
had significantly lower plasma concentrations of LDL-C,
in comparison with I and II group. While the HDL-C
level was significantly increased in the treated group
with garlic in comparison with rats fed a high-fat diet.
Our results suggest that administration of high doses of
garlic extracts shows protective effects on HDL in rats
with high LDL intake (Fig. 4)(Tables 4 and 6).
Discussion
Natural remedies have been investigated for centuries for
a wide variety of ailments. Among them, garlic has re-
ceived special attention for its beneficial effects [30–36].
Common available garlic preparations in the form of garlic
oil, garlic powder and pills are widely used for certain
therapeutic purposes, including lowering blood pressure
and improving lipid profile [37–39]. Despite the impres-
sive effects of garlic, most studies are limited by lack of
controlled methods and by the use of reparations with un-
known amounts and chemical identification of the active
ingredient. Therefore this study was designed to examine
the effects of raw and boiled garlic and their aqueous ex-
tracts on lipid, antioxidant and protein status in serum of
rats. For this purpose, Wistar rats were fed diets with gar-
lic and cholesterol supplements.
Table 3 Effects of daily administration of garlic extract on plasma LDL profile for 4 weeks in male albino Wistar rats
Groups Compared with groups Mean difference (I-J) Std. Error Sig. Lower bound Upper bound
1 2 4.8000 3.05666 .625 −14.2510 4.6510
3 −5.24000* 3.05666 .526 −14.6910 4.2110
4 −12.80000* 3.05666 .004 −22.2510 −3.3490
2 1 12.80000 3.05666 .004 3.3490 22.2510
3 1.40000 3.05666 .997 −8.0510 10.8510
4 8.00000 3.05666 .132 −1.4510 17.4510
3 1 11.40000* 3.05666 .012 1.9490 20.8510
2 6.60000 3.05666 .293 −2.8510 16.0510
4 −1.40000 3.05666 .997 −10.8510 8.0510
4 1 12.80000* 3.05666 .004 3.3490 22.2510
2 8.00000 3.05666 .132 −1.4510 17.4510
3 1.40000 3.05666 .997 −8.0510 10.8510
Table 4 Effects of daily administration of garlic extract on plasma HDL profile for 2 and 4 weeks in male albino Wistar rats. The 95 %
confidence interval of recalculated
Time Groups Mean ± SEM Lower bound Upper bound
2wk Control 41.4000 ± 3.64692 36.8718 45.9282
2wk hypercholesterolemic controls 28.0000 ± 4.35890 22.5877 33.4123
2wk dose of 200 mg/kg/bw of garlic extract 36.6000 ± .89443 35.4894 37.7106
2wk dose of 400 mg/kg/bw of garlic extract 37.4000 ± 3.64692 32.8718 41.9282
2wk Total 41.4000 ± 2.96463 34.7494 40.0506
4wk Control 52.8000 ± 7.19027 43.8721 61.7279
4wk hypercholesterolemic controls 29.6000 ± 9.39681 17.9323 41.2677
4wk dose of 200 mg/kg/bw of garlic extract 31.4000 ± 4.33590 26.0163 36.7837
4wk dose of 400 mg/kg/bw of garlic extract 33.2000 ± 3.27109 29.1384 37.2616
4wk Total 82.5000 ± 7.20917 34.6368 42.9632









This study has shown that administration of 200 mg/kg/
bw, especially 400 mg/kg/bw dietary garlic significantly at-
tenuated serum LDL levels and increased HDL levels in
when fed 1 % cholesterol in the fed rats. The significant
reduction in the ratio of LDL to HDL/LDL with garlic
suggests potential health benefits of garlic supplementa-
tion in reduction of coronary artery disease and/or athero-
sclerosis and/or similar to those described in the field
malignant cholesterol diseases. Our findings were in
agreement with other studies, which announced that gar-
lic consumption increased HDL-C level in hyperlipidemic
patients [7], animals [40], and patients with coronary ar-
tery disease [41]. When garlic supplements was added into
the diet at a concentration of 1 %, LDL-C level was de-
creased and HDL-C level were increased in rabbits [42],
resulting in a decrease in the LDL-C/HDL-C ratio. More-
over, our observations reveal that the dietary garlic ex-
tracts may have cardiovascular diseases protection effects
by regulating the LDL-C/HDL-C ratio.
Furthermore, in vivo and in vitro studies in recent
years have demonstrated that garlic has cholesterol
and triglyceride-lowering, antibacterial, hypoglycemic,
hypotensive potential and anti-aggregatory properties
[24, 43–45]. The effects of garlic on serum lipid levels
have been investigated in human and animal models and
indicate inconsistency in the reported results [46],which
according to these findings can be expressed that our re-
sults is exactly in agreement with those mentioned. and,
when compared to groups I and II, the significant im-
provement of lipid profiles in group III and IV rats treated
simultaneously with garlic extracts agrees with the previ-
ous studies that garlic is a hypolipidemic agent [47] that
can help in decreasing the level of LDL-C and in increas-
ing the level of HDL-C. In parallel to, in hypertensive
patients, Durak et al. reported that garlic extract supple-
mentation improves blood lipid profile, strengthens blood
antioxidant potential and decreases the level of malondial-
dehyde in blood samples [48], and also, another study by
Table 5 Effects of daily administration of garlic extract on plasma HDL profile for 2 weeks in male albino Wistar rats
Groups Compared with groups Mean difference (I-J) Std. Error Sig. Lower bound Upper bound
1 2 13.40000 2.99333 .002 4.1448 22.6552
3 4.80000 2.99333 .604 −4.4552 14.0552
4 4.00000a 2.99333 .763 −5.2552 13.2552
2 1 −13.40000 2.99333 .002 −22.6552 −4.1448
3 −8.60000 2.99333 .079 −17.8552 .6552
4 −9.40000a 2.99333 .045 −18.6552 -.1448
3 1 −4.80000 2.99333 .604 −14.0552 4.4552
2 8.60000 2.99333 .079 -.6552 17.8552
4 -.80000 2.99333 1.000 −10.0552 8.4552
4 1 −4.00000a 2.99333 .763 −13.2552 5.2552
2 9.40000** 2.99333 .045 .1448 18.6552
3 8.0000 2.99333 1.000 −8.4552 10.0552
aSignificant as compared to another groups
Table 6 Effects of daily administration of garlic extract on plasma HDL profile for 4 weeks in male albino Wistar rats
Groups Compared with groups Mean difference (I-J) Std. Error Sig. Lower bound Upper bound
1 2 23.20000 3.97240 .000 10.9176 35.4824
3 21.40000* 3.97240 .000 9.1176 33.6824
4 19.60000* 3.97240 .001 7.3176 31.8824
2 1 −23.20000 3.97240 .000 −35.4824 −10.9176
3 −1.80000* 3.97240 .997 −14.0824 10.4824
4 −3.60000* 3.97240 .941 −15.8824 8.6824
3 1 −21.40000* 3.97240 .000 −33.6824 −9.1176
2 −19.60000* 3.97240 .001 −31.8824 −7.3176
4 1.80000 3.97240 .997 −10.4824 14.0824
4 1 −19.60000* 3.97240 .001 −31.8824 −7.3176
2 −17.80000* 3.97240 .002 −30.0824 −5.5176
3 1.80000 3.97240 .997 −10.4824 14.0824









Fig. 1 Effect of garlic extracts (200 and 400 mg/kg) on serum LDL levels in comparison with the control and hypercholesterolemic groups for
2 weeks on the activity of LDL. Note that statistically significant difference from the control group with other groups. *Significant as compared to
200 mg/kg group. Bars are expressed as mean ± SEM (n = 10). P < 0.05
Fig. 2 Effect of garlic extracts (200 and 400 mg/kg) on serum LDL levels in comparison with the control and hypercholesterolemic groups for
4 weeks on the activity of LDL. Note that statistically significant difference from the control group with other groups . Bars are expressed as
mean ± SEM (n = 10). P < 0.05









Bordia et al., showed that in patients suffering from cor-
onary artery disease, administration of garlic significantly
decreased serum LDL and increased HDL[41]. In a human
study, supplementation with raw garlic, powdered garlic,
or aged garlic extract (4 g/day) for 6 months significantly
lowered LDL-C and other plasma lipid levels in adults
with moderate hypercholesterolemia [49]. Our findings in
rats provide further support for the anti-hyperlipidemic,
and anti-hypercholesterolemic of processed garlic prod-
ucts and garlic exhibited remarkable anti-hyperlipidemic
action by decreasing the levels of LDL-C in plasma for
groups control and % 1 fed with cholesterol diet and
Fig. 3 Effect of garlic extracts (200 and 400 mg/kg) on serum HDL levels in comparison with the control and hypercholesterolemic groups for
2 weeks on the activity of HDL. Note that statistically significant difference from the control group with other groups . Bars are expressed as
mean ± SEM (n = 10). P < 0.05
Fig. 4 Effect of garlic extracts (200 and 400 mg/kg) on serum HDL levels in comparison with the control and hypercholesterolemic groups for
2 weeks on the activity of HDL. Note that statistically significant difference from the control group with other groups.* Significant as compared to
control group with treatment groups. Bars are expressed as mean ± SEM (n = 10). P < 0.05









increasing the level of HDL for groups with doses
200 mg/kg and 400 mg/kg, respectively. Although signifi-
cant reductions in blood cholesterol and triglyceride levels
were found in some studies when garlic extract or powder
were utilized, no satisfactory agreement has been reached
on this kind of clinical and experimental data[49].
Conclusions
In conclusion, the high doses of garlic extracts amelio-
rated plasma lipid profiles by decreasing the LDL-C level
and increasing the HDL-C level in high-fat fed rats.
Therefore, our findings revealed that the garlic extract
treatment can lower blood cholesterol level, such as LDL
and can improve blood lipid profile to a significant extent,
such as HDL. Finally, it has been recommended that ex-
tracts such as garlic that are rich in anti-hyperlipidemic,
and anti-hypercholesterolemic contents may confer bene-
ficial effects in this regard to atherosclerotic processes.
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